Publication | Closed Access

Fibroblast growth factor 21 alleviates idiopathic pulmonary fibrosis by inhibiting PI3K-AKT-mTOR signaling and stimulating autophagy

InflammationAntifibrotic TherapyFibrosisInflammatory Lung DiseaseAdvanced Lung DiseaseLung InflammationAutophagyImmunologyPathologyFibroblast Growth FactorPulmonary FibrosisPi3k-akt-mtor SignalingMedicineCell BiologyCell SignalingStimulating Autophagy